Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis.
<h4>Background</h4>Effective drug treatments for Covid-19 are needed to decrease morbidity and mortality for the individual and to alleviate pressure on health care systems. Remdesivir showed promising results in early randomised trials but subsequently a large publicly funded trial has...
Main Authors: | Asger Sand Paludan-Müller, Andreas Lundh, Matthew J Page, Klaus Munkholm |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0260544 |
Similar Items
-
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
by: Alejandro Piscoya, et al.
Published: (2020-01-01) -
Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis
by: Vikas Bansal, et al.
Published: (2021-01-01) -
Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review
by: Asger S. Paludan-Müller, et al.
Published: (2021-04-01) -
Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials
by: Desye Gebrie, et al.
Published: (2020-06-01) -
Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
by: Mohammad Tasavon Gholamhoseini, et al.
Published: (2021-05-01)